Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: Adv Drug Deliv Rev. 2016 Nov 30;119:20–43. doi: 10.1016/j.addr.2016.11.003

Table 1.

Representative examples of angiogenesis modulation via non-viral nanoparticle-based gene delivery

Angiogenesis Disease Factor Delivery Vector Animal
Model
Injection Result Reference
Pro Ischemic
Limb
VEGF165 Heparin-PEI Mice Intramuscular Over 3-fold ↑ neovasulazation vs.
PEI in ischemic limb
[116]
VEGF PBAE Mice exwVoHUVEC
transfection
Limb salvage 50% compared to
lipoplex (30%) and PEI (12.5%)
[140]
eNOS Elastin-based polymer Mice Intramuscular ~ 3-fold ↑ perfusion ratio and blood
vessel density vs. control
[120]
Myocardial
In fact
Adreno-
medulliln
Dextran Rats ex vivo MSC
transfection
2.5-fold ↑ capillary density and
40% ↓ infarct size vs. control
[131]
VEGF165 Chitosan-g-PEI Rats Intramyocardial 1.6-fold ↑ejection fraction and
vessel density vs. PEI control
[117]
Hypoxia-
inducible
VEGF165
Cholesterol
chloroformate-bPEI
Rabbits Intramyocardial Myocardial infarct size (36% ↓)
vs. vector alone without hypoxia-
inducible VEGF165
[119]
VEGF165 PLGA Rabbits Intramyocardial Capillary density (38% ↑) vs.
plasmid only
[124]
Tissue
Engineering
SHh PBAE Mice Transdermal 15% ↑ wound closure than PBS [150]
VEGF PBAE Mice ex vivo ASC
transfection
20% ↑ wound closure than non-
modified ASC
[151]
PDGF-B PEI Rats collagen scaffold
with PEI-pPDGF
40% bone volume and 52-fold ↑
connective density vs. control
[154]
Anti Cancer sFlt-1 or
siVEGFRI
bPEI-g-PEG-cRGD Mice Intravenous 3-fold / 42% ↓ colon carcinoma
umor growth vs. PEI-g-PEG
[214,216]
NF-kB Tween-SS-bPEI Mice Intravenous Breast tumor volume 6% of saline [218]
Endostatin PVP Mice Intramuscular 60% ↓ metastatic brain tumor
growth vs. control by MRI
[220]
shVEGF/ DOX CPP-dendrimer PLL Mice Intravenous VEGF mRNA (65% ↓) and
median survival (2-fold ↑) vs.
control in orthotopic glioma
[224]
siVEGF guanidine-βCD-PEG-
anisamide
Mice Intravenous VEGF mRNA(3.5-fold ↓) / prostate
tumor growth(3-fold ↓) vs. control
[228]
Age-related
Macular
Degenera
tion
Vasostatin PVP Rats Intramuscular 32.5% / 48% decrease in CNV
incidence and area at day 42
[247]
shHIF-1α PLGA Rats Intravitreal Leakage (50%↓) / lesion
thickness (40%↓) vs. control
[248]
Flt23k RGD-PLGA Monkey/
Mice
Intravenous CNV area 53% (monkey) and
43% (mice) ↓ vs. sham
[252]